VG Life Sciences secures patent covering treatment of IDB with CLIP-inducing agent

(Viral Genetics, Inc.) VG Life Sciences, a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the US Patent and Trademark Office has issued US Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.

http://www.eurekalert.org/pub_releases/2015-01/vgi-vls012815.php

Source: EurekAlert! - Medicine and Health - January 30, 2015 Category: Global & Universal Source Type: news